Posted on 10/20/2025 10:22:40 PM PDT by Morgana
Afaxys Pharma — which supplies "family planning clinics" and Planned Parenthood facilities, universities, and others with birth control and emergency contraceptives — has received $8 million in funding from an abortion pill investor, allegedly for "improving access to affordable contraceptives across the United States." And a former Planned Parenthood manager is set to lead the for-profit company.
Key Takeaways:
* A 'contraceptive' pharmacy heavily tied to Planned Parenthood and at least one abortion pill distributor has received millions from two foundations — one of which is one of the largest global funders of abortion.
* The funding, from the Packard Foundation and an anonymous foundation, is allegedly earmarked for a "novel contraceptive product" to be promoted to "marginalized communities."
* Internal Planned Parenthood documents have reportedly referred to the for-profit pharmacy as being "Planned Parenthood affiliated."
The Details:
A recent release published at Newsweek noted that the $8 million given to Afaxys came from well-known abortion pill investor, the David and Lucile Packard Foundation, and an "anonymous" foundation. Where we see Packard funding, we often also see funding from the Susan Thompson Buffett Foundation (Warren Buffett), which has been frequently revealed later as the "anonymous" donor.
The release also stated that Christian Bloomgren, a "former general manager at Planned Parenthood Federation North America," will "take over" Afaxys — and he is not the first executive with ties to both Planned Parenthood and Afaxys.
Third investment from Packard shows 'long-standing partnership'
The David and Lucile Packard Foundation invested $14.2 million in abortion pill manufacturer Danco Laboratories in 1996 and is today investing millions in the first generic version of the drug made by GenBioPro, as well as funding clinical trial sponsors, study sites, and authors. An August 2025 press release describes the foundation's funding of Afaxys (emphases added):
The capital includes a $3 million program-related investment (PRI) from the David and Lucile Packard Foundation and a $5 million grant from an anonymous foundation. This marks the third investment from the Packard Foundation since Afaxys was founded in 2008, underscoring the long-standing partnership and confidence in Afaxys’ impact-driven model.
... Afaxys plays a critical role in ensuring reliable supply chains for clinics that serve Medicaid and Title X patients. The funding will be used to complete the development of a novel contraceptive product, specifically designed to address the needs of marginalized communities and the more than 19 million women living in contraceptive deserts.
... The Afaxys enterprise comprises a family of companies that operate under three wholly owned subsidiaries: Afaxys Pharma, LLC, Afaxys Drug Development, LLC and Afaxys Group Services, LLC (AGS). Afaxys Pharma provides a broad portfolio of branded and generic contraceptives to the public healthcare market. Afaxys Drug Development provides development and regulatory services of pharmaceutical products with a focus on rapid and efficient launch readiness to promote Afaxys’ strategic goal of cost-conscious product commercialization. AGS is a strategic sourcing operation that negotiates favorable pricing across a broad base of products and services through its Group Purchasing Organization. For more information, visit www.afaxys.com.
Packard's 2016 report claimed, "The Packard Foundation provided a $4.5 million low-interest loan to serve as growth capital to expand Afaxys to a national presence and enabled it to launch its private label contraceptives."
Packard also funds the National Abortion Federation (NAF), NARAL, and the Population Council — the last of which brought the drug to the U.S. and set up Danco — and is a substantial donor to Planned Parenthood as well as FemHealth, Gynuity Health and others. The Background:
Afaxys (the name of which is a combination of "affordable" and "access"), located in Charleston, South Carolina, "serves more than 6,700 health care sites and the launch of multiple contraceptive products." Ties to Planned Parenthood
Afaxys is an Amazon retailer and was co-founded in 2008 by current CEO Ronda Dean, who claimed she received contraceptives from Planned Parenthood as a teen and went on to work as vice president of Planned Parenthood Federation of America.
An archived website from Planned Parenthood Minnesota, North Dakota, South Dakota (PPMNS) claimed Afaxys was also co-founded by Sarah Stoesz, PPMNS's former President & CEO, who remains as Board Chair of Afaxys.
According to PharmaVoice.com, Afaxys "licenses products and provides them under its own label to the public healthcare market" and "offers 12 different products: 10 oral contraceptives, an emergency contraceptive and injectable anesthetic lidocaine, its first non-contraceptive product." The website noted:
Afaxys also has its own drug currently in development — although Dean wouldn’t divulge much about it, she said it was “a new form of contraception” that “will be of great interest.”
A report published by American Life League (ALL) added that "Afaxys is essentially part of the Planned Parenthood empire":
If women have complications from the abortion pill they simply go to the local ER just like when the abortion clinic was open.
Same as it ever was.
Hoping it stays up.
ping
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.